Immuneering Corp — Investor Relations & Filings
Immuneering Corp. is a clinical-stage oncology company focused on developing medicines for broad populations of cancer patients. The company utilizes its proprietary computational Disease Cancelling Technology to design and develop novel therapeutics. Its lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily deep cyclic inhibitor of the MEK pathway. Atebimetinib is being evaluated in Phase 2a clinical trials for patients with advanced solid tumors, including pancreatic cancer. The drug is designed to maximize therapeutic activity while providing an improved tolerability profile, with the goal of helping patients outlive their disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A | 2025-04-21 | English | |
| FORM 4 | 2025-03-24 | English | |
| FORM 3 | 2025-03-24 | English | |
| 424B5 | 2025-03-20 | English | |
| 10-K | 2025-03-20 | English | |
| 8-K | 2025-03-20 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13211558 | DEF 14A | 2025-04-21 | English | ||
| 13211559 | FORM 4 | 2025-03-24 | English | ||
| 13211560 | FORM 3 | 2025-03-24 | English | ||
| 13211561 | 424B5 | 2025-03-20 | English | ||
| 13211562 | 10-K | 2025-03-20 | English | ||
| 13211563 | 8-K | 2025-03-20 | English | ||
| 13211564 | FORM 4 | 2025-02-07 | English | ||
| 13211565 | FORM 4 | 2025-02-07 | English | ||
| 13211566 | FORM 4 | 2025-02-07 | English | ||
| 13211567 | FORM 4 | 2025-02-07 | English | ||
| 13211568 | FORM 4 | 2025-02-07 | English | ||
| 13211569 | FORM 4 | 2025-02-07 | English | ||
| 13211571 | Major Shareholding Notification 2025 | 2025-01-17 | English | ||
| 13211573 | 8-K | 2025-01-13 | English | ||
| 13211574 | 8-K | 2025-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Immuneering Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32973/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32973 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32973 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32973 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32973}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immuneering Corp (id: 32973)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.